Accelerate to discover
Related topics
Discover the Celloger live-cell analyzers : miniaturized and powerful tools for every Biologist
Apr 5, 2024
Celloger live-cell analyzers, image and analyze your cells in real-time, inside your incubator. With its exceptional...
Webinar: Multimodal Assessment of Hypoxia in Tumors: From the Lab to the Clinic
Apr 2, 2024
25 April 2024, 4PM CET
This webinar will be of interest to multiple profiles in the community of biomedical...
Multiplexed tissue imaging using the Orion platform to reveal the Spatial Biology of Cancer
Mar 27, 2024
In this webinar Prof. Sandro Santagata, will reveal how Orion high-plex imaging and the use of this data, is valuable...
Discover Yokogawa CellVoyager CQ1: Benchtop High-Content Analysis System
Mar 8, 2024
Unlike flow cytometers, the CellVoyager CQ1 confocal quantitative image cytometer does not require pretreatment such as...
Improve your data resolution with Cytek Autofluorescence Extraction tool!
Feb 5, 2024
Samples with high autofluorescence (AF) can be difficult to resolve with conventional flow cytometry, especially if...
Webinar: transforming Calcium Flux analysis with Cytek Full Spectrum Profiling Technology
Jan 4, 2024
The research described in this webinar harnesses the innovative capabilities of FSP technology to perform advanced...
Webinar recording: BioFlux, the gold standard for Platelet Biology and Vascular Pharmacology studies
Jan 3, 2024
The BioFlux system give you the ability to introduce physiological shear flow to your research and drug discovery...
Explore the new Agilent Cell Therapy virtual lab
Jan 2, 2024
As the Cell and Gene therapy space expands rapidly, highly sophisticated technologies and instrumentation are required...
Nov 22, 2018
Researchers developed an assay to measure CLL cell interactions with endothelium under shear force using a Bioflux 200 and blocked CD62L using the anti-CD62L antibody DREG-56. CLL cell interactions with endothelium were visualized by time-lapse microscopy and CLL cell movement was tracked and quantified. Data will be discussed in the webinar and will establish targeting CD62L inhibits CLL cell/endothelial cell interactions and is accentuated by co-administration with ibrutinib. These data imply that some of the clinical effects caused by ibrutinib are due to a reduced capacity of CLL cells to engage endothelium and extravasate.
Dr. Chris Pepper, Professor in Cancer Studies, University of Sussex, UK
Related technologies: Cell interaction studies
Get more info
Brand profile
With BioFlux System for live cell analysis under shear flow and IsoFlux System for circulating tumor cell analysis, Fluxion Biosciences turn power of benchtop cellular analysis with advanced tools to automate complex assays.
More info at:
www.fluxionbio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
